Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenner C Rice

Showing results (151-160 of 403) with videos related to

Pageof 41
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 3, 2003
The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in ratsMary M Torregrossa, Ceylan Isgor, John E Folk, et al.
Addiction Biology|November 15, 2019
Stereoselective neurochemical, behavioral, and cardiovascular effects of α-pyrrolidinovalerophenone enantiomers in male ratsCharles W Schindler, Eric B Thorndike, Hailey M Walters, et al.
Psychopharmacology|August 21, 2007
The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in ratsPeter W Marinelli, Douglas Funk, Walter Juzytsch, et al.
Pharmacology, Biochemistry, and Behavior|November 5, 2017
Antagonism of the kappa opioid receptor attenuates THC-induced place aversions in adult male Sprague-Dawley ratsMatthew M Clasen, Shaun M Flax, Briana J Hempel, et al.
Analytica Chimica Acta|May 17, 2014
3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography-high resolution mass spectrometrySebastien Anizan, Kayla Ellefsen, Marta Concheiro, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 11, 2013
CRF-CRF1 receptor system in the central and basolateral nuclei of the amygdala differentially mediates excessive eating of palatable foodAttilio Iemolo, Angelo Blasio, Stephen A St Cyr, et al.
Psychoneuroendocrinology|March 8, 2008
Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeysJohn E Pascoe, Keith L Williams, Partha Mukhopadhyay, et al.
Neuropharmacology|March 30, 2019
Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA)Daniel W Curry, Laís F Berro, Andie R Belkoff, et al.
Pharmacological Reviews|July 15, 2011
Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesiaMark R Hutchinson, Yehuda Shavit, Peter M Grace, et al.
The Journal of Biological Chemistry|December 3, 2011
Recombinant cannabinoid type 2 receptor in liposome model activates g protein in response to anionic lipid constituentsTomohiro Kimura, Alexei A Yeliseev, Krishna Vukoti, et al.
Pageof 41

Showing results (151-160 of 403) with videos related to

Sort By:
Pageof 41
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 3, 2003
The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in ratsMary M Torregrossa, Ceylan Isgor, John E Folk, et al.
Addiction Biology|November 15, 2019
Stereoselective neurochemical, behavioral, and cardiovascular effects of α-pyrrolidinovalerophenone enantiomers in male ratsCharles W Schindler, Eric B Thorndike, Hailey M Walters, et al.
Psychopharmacology|August 21, 2007
The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in ratsPeter W Marinelli, Douglas Funk, Walter Juzytsch, et al.
Pharmacology, Biochemistry, and Behavior|November 5, 2017
Antagonism of the kappa opioid receptor attenuates THC-induced place aversions in adult male Sprague-Dawley ratsMatthew M Clasen, Shaun M Flax, Briana J Hempel, et al.
Analytica Chimica Acta|May 17, 2014
3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography-high resolution mass spectrometrySebastien Anizan, Kayla Ellefsen, Marta Concheiro, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 11, 2013
CRF-CRF1 receptor system in the central and basolateral nuclei of the amygdala differentially mediates excessive eating of palatable foodAttilio Iemolo, Angelo Blasio, Stephen A St Cyr, et al.
Psychoneuroendocrinology|March 8, 2008
Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeysJohn E Pascoe, Keith L Williams, Partha Mukhopadhyay, et al.
Neuropharmacology|March 30, 2019
Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA)Daniel W Curry, Laís F Berro, Andie R Belkoff, et al.
Pharmacological Reviews|July 15, 2011
Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesiaMark R Hutchinson, Yehuda Shavit, Peter M Grace, et al.
The Journal of Biological Chemistry|December 3, 2011
Recombinant cannabinoid type 2 receptor in liposome model activates g protein in response to anionic lipid constituentsTomohiro Kimura, Alexei A Yeliseev, Krishna Vukoti, et al.
Pageof 41